Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer

[1]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[2]  P. Laurent-Puig,et al.  Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. , 2008, Cancer research.

[3]  W. Samowitz.  Genetic and epigenetic changes in colon cancer. , 2008, Experimental and molecular pathology.

[4]  Z. Herceg,et al.  Epigenetic drivers and genetic passengers on the road to cancer. , 2008, Mutation research.

[5]  A. Feinberg,et al.  Intra-individual change over time in DNA methylation with familial clustering. , 2008, JAMA.

[6]  S. Ogino,et al.  LINE‐1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer , 2008, International journal of cancer.

[7]  M. Kloor,et al.  Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. , 2008, Gastroenterology.

[8]  N. Brockton.  Systemic folate status and risk of colorectal cancer , 2008, Cancer Causes & Control.

[9]  A. Feinberg.  Epigenetics at the epicenter of modern medicine. , 2008, JAMA.

[10]  M. Szyf,et al.  Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo. , 2008, Neoplasia.

[11]  G. Varela-Moreiras,et al.  Folate status and S-adenosylmethionine/S-adenosylhomocysteine ratio in colorectal adenocarcinoma in humans , 2008, European Journal of Clinical Nutrition.

[12]  J. Little,et al.  Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case–control study in a population with relatively low folate intake , 2008, British Journal of Nutrition.

[13]  R. Sinha,et al.  Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. , 2008, Gastroenterology.

[14]  V. D’Almeida,et al.  Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation. , 2007, Neoplasia.

[15]  S. Ogino,et al.  IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53. , 2007, Neoplasia.

[16]  Minoru Toyota,et al.  Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer , 2007, Proceedings of the National Academy of Sciences.

[17]  M. Fraga,et al.  Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway. , 2007, Neoplasia.

[18]  P. Neuhaus,et al.  The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients. , 2007, Neoplasia.

[19]  C. Ulrich,et al.  Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. , 2007, Carcinogenesis.

[20]  D. Hunter,et al.  Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study. , 2007, Carcinogenesis.

[21]  J. Issa,et al.  LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability , 2007, PloS one.

[22]  M. Loda,et al.  Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. , 2007, The Journal of molecular diagnostics : JMD.

[23]  R. Houlston,et al.  MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer. , 2007, Human molecular genetics.

[24]  R. Moriggl,et al.  Signal Transducer and Activator of Transcription 3 Activation Promotes Invasive Growth of Colon Carcinomas through Matrix Metal loproteinase Induction , 2007 .

[25]  Debashis Ghosh,et al.  Feature selection and molecular classification of cancer using genetic programming. , 2007, Neoplasia.

[26]  Chun-Min Lo,et al.  Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin. , 2007, Neoplasia.

[27]  P. Malfertheiner,et al.  Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression. , 2007, Neoplasia.

[28]  R. Wolff,et al.  Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer , 2007, International journal of cancer.

[29]  M. van Engeland,et al.  Dietary Folate Intake in Combination with MTHFR C677T Genotype and Promoter Methylation of Tumor Suppressor and DNA Repair Genes in Sporadic Colorectal Adenomas , 2007, Cancer Epidemiology Biomarkers & Prevention.

[30]  R. Moriggl,et al.  Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. , 2007, Neoplasia.

[31]  W. Willett,et al.  Nonsynonymous Polymorphisms in Genes in the One-Carbon Metabolism Pathway and Associations with Colorectal Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[32]  N. Brockton.  Localized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate? , 2006, Cancer Causes & Control.

[33]  M. Fraga,et al.  Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. , 2006, Cancer research.

[34]  M. Loda,et al.  CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies , 2006, Gut.

[35]  P. Laird,et al.  CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.

[36]  D. Hunter,et al.  O6-Methylguanine-DNA Methyltransferase Leu84Phe and Ile143Val Polymorphisms and Risk of Colorectal Cancer in the Nurses’ Health Study and Physicians’ Health Study (United States) , 2006, Cancer Causes & Control.

[37]  Shuji Ogino,et al.  Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. , 2006, The Journal of molecular diagnostics : JMD.

[38]  Kentaro Yamashita,et al.  Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. , 2006, Cancer cell.

[39]  J. Luketich,et al.  Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. , 2006, Neoplasia.

[40]  S. Matsui,et al.  Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. , 2005, Cancer research.

[41]  R. Jaenisch,et al.  Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Wolff,et al.  Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. , 2005, Gastroenterology.

[43]  Graham A. Colditz,et al.  The Nurses' Health Study: lifestyle and health among women , 2005, Nature Reviews Cancer.

[44]  A. Camargo,et al.  Colorectal cancer "methylator phenotype": fact or artifact? , 2005, Neoplasia.

[45]  D. Hunter,et al.  APC Asp1822Val and Gly2502Ser Polymorphisms and Risk of Colorectal Cancer and Adenoma , 2005, Cancer Epidemiology Biomarkers & Prevention.

[46]  R. Lothe,et al.  Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. , 2005, Neoplasia.

[47]  E. Giovannucci.  Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. , 2004, The Journal of nutrition.

[48]  N. Matsubara,et al.  BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum , 2004, Gut.

[49]  D. Hunter,et al.  Polymorphisms in the one‐carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study , 2004, International journal of cancer.

[50]  R. Bostick,et al.  Folate Intake, MTHFR C677T Polymorphism, Alcohol Consumption, and Risk for Sporadic Colorectal Adenoma (United States) , 2004, Cancer Causes & Control.

[51]  G. Watanabe,et al.  The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer. , 2004, Anticancer research.

[52]  J. Issa,et al.  A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. , 2004, Nucleic acids research.

[53]  S. Apostolidou,et al.  An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. , 2003, Human molecular genetics.

[54]  A. Schatzkin,et al.  Folate, methionine, alcohol, and colorectal cancer in a prospective study of women in the United States , 2002, Cancer Causes & Control.

[55]  G. Watanabe,et al.  The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  D. Riesner,et al.  Induction of Tumors in Mice by Genomic Hypomethylation , 2003 .

[57]  D. Girelli,et al.  A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J H Eckfeldt,et al.  The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. , 2001, Atherosclerosis.

[59]  A. D. Smith,et al.  Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. , 2000, Human molecular genetics.

[60]  P. Laird,et al.  MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.

[61]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[62]  K. Livak,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay. , 1999, Genetic analysis : biomolecular engineering.

[63]  T Foitzi,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay , 1999 .

[64]  M. Ehrlich,et al.  DNA demethylation and pericentromeric rearrangements of chromosome 1. , 1997, Mutation research.

[65]  E. Rimm,et al.  Folate, methionine, and alcohol intake and risk of colorectal adenoma. , 1993, Journal of the National Cancer Institute.